摘要
Abstract
Objective To evaluate the clinical effect of vinpocetine treating vertebrobasilar insufficient (VBI). Methods 87 patients with VBI treated in our hospital from March 2011 to December 2013 were selected and randomly divided into the observation group (n=44)and the control group (n=43).The observation group was treated with vinpocetine,while the control group was treated with hydrochloric acid difenidol.After one week,the clinical efficacy,average blood flow velocity of vertebral artery and basilar artery in the two groups were compared. Results In the observation group,25 cas-es (56.8%) were excellent,13 cases (29.5%) were good and 6 cases (13.6%) were bad,while in the control group they were 15 cases (34.9% ),12 (27.9%) and 16 (37.2%)respectively,and there was a statistical difference of clinical effect of the two grouos (P<0.05).In the observation group,the left average blood flow velocity was (36.9±7.3) cm/s,the right aver-age blood flow velocity was (39.1±6.3) cm/s,the average blood flow velocity of basilar artery was (40.1±4.9) cm/s,while they were (30.3±5.7) cm/s,( 29.5±6.3) cm/s,(33.8±7.0) cm/s respectively and there was a statistical difference of average blood flow velocity of vertebral artery and basilar artery in the two groups (P<0.05). Conclusion The clinical effect of vinpocetine treating VBI is good,it can significantly increase the blood flow of vertebrobasilar artery.It is worthy of clin-ical promotion.关键词
长春西汀/椎基底动脉/疗效Key words
Vinpocetine/Vertebrobasilar artery/Efficacy分类
医药卫生
